BOHLIN GAREN G 4
4 · TETRAPHASE PHARMACEUTICALS INC · Filed Jun 11, 2019
Insider Transaction Report
Form 4
BOHLIN GAREN G
Director
Transactions
- Award
Stock option (right to buy)
2019-06-10+16,500→ 16,500 totalExercise: $0.77Exp: 2029-06-09→ Common Stock (16,500 underlying)
Footnotes (1)
- [F1]Vests in equal quarterly installments over a one-year period measured from the date of grant.